Morphologic characteristics of hypertrophic cardiomyopathy of the elderly with cardiac myosin-binding protein C gene mutations

Circulation Journal

Volumn 70, Issue 7, 2006, Pages 875-879

  Hirota, Takayoshi ^a   Kitaoka, Hiroaki ^a   Kubo, Toru ^a   Okawa, Makoto ^a   Furuno, Takashi ^a   Doi, Yoshinori L ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cardiac myosin binding protein C mutation; Elderly; Hypertrophic cardiomyopathy; Morphology

Indexed keywords

BINDING PROTEIN; CARDIAC MYOSIN; CARDIAC MYOSIN BINDING PROTEIN C; PROTEIN C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; HEART SEPTUM; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MUTATION; VENTRICULAR MYOSINS;

EID: 33745539045     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.875     Document Type: Article

References (24)

1. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002; 287: 1308-1320.
2. Elliot P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004; 363: 1881-1891.
3. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation 1995; 92: 1680-1692.
4. Fay WP, Taliercio CP, Ilstrup DM, Tajik AJ, Gersh BJ. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol 1990; 16: 821-826.
5. Maron BJ, CaseySA, Hauser RG, Appli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol 2003; 42: 882-888.
6. Shapiro LM. Hypertrophic cardiomyopathy in the elderly. Br Heart J 1990; 63: 265-266.
7. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, et al. Mutations in the gene for human cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998; 338: 1248-1257.
8. Van Driest SL, Jaeger MA, Ommen SR, Will ML, Gersh BJ, Tajik AJ, et al. Comprehensive analysis of beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44: 602-610.
9. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44: 1903-1910.
10. Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, et al. Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001; 38: 315-321.
11. Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002; 105: 446-451.
12. Lever HM, Karam RF, Currie P, Healy BP. Hypertrophic cardiomyopathy in the elderly: Distinctions from the young based on cardiac shape. Circulation 1989; 79: 580-589.
13. Lewis JF, Maron BJ. Elderly patients with hypertrophic cardiomyopathy: A subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 1989; 13: 36-45.
14. Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥65 years of age. Am J Cardiol 1994; 73: 1105-1111.
15. Kubo T, Kitaoka H, Okawa M, Matsumura Y, Hitomi N, Yamasaki N, et al. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac myosin-binding protein C gene among Japanese. J Am Coll Cardiol 2005; 46: 1737-1743.
16. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide-angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428.
17. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437-444.
18. Okawa M, Kitaoka H, Matsumura Y, Kubo T, Yamasaki N, Furuno T, et al. Functional assessment by myocardial performance index (Tei Index) correlates with plasma brain natriuretic peptide concentration in patients with hypertrophic cardiomyopathy. Circ J 2005; 69: 951-957.
19. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, et al. Hypertrophic cardiomyopathy: The importance of the site and the extent of hypertrophy: A review. Prog Cardiovasc Dis 1985; 28: 1-83.
20. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997; 16: 379-382.
21. Anan R, Niimura H, Minagoe S, Tei C. A novel deletion mutation in the cardiac myosin-binding protein C gene as a cause of Maron type IV hypertrophic cardiomyopathy. Am J Cardiol 2002; 89: 487-488.
22. Ogimoto A, Hamada M, Nakura J, Shigematsu Y, Hara Y, Ohtsuka T, et al. 17-year follow-up study of a patients with obstructive hypertrophic cardiomyopathy with a deletion mutation in the cardiac myosin binding protein C gene. Circ J 2004; 68: 174-177.
23. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985; 312: 277-283.
24. Karam R, Lever HM, Healy BP. Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol 1989; 13: 580-584.